What a peptide is
A peptide is a short chain of amino acids, the same building blocks that make up proteins. The usual line is drawn somewhere around fifty amino acids: shorter than that and it is called a peptide, longer and it is called a protein. The line is a convention, not a law of nature, but it points at something real. Small chains are made, moved, and broken down differently from large folded proteins.
Your body makes peptides constantly. Many of the messages that pass between organs are peptides: oxytocin is nine amino acids long, and GLP-1, the hormone behind a whole category of approved weight and diabetes medicines, is about thirty. When you hear “peptide” online, it can mean a hormone your body already makes, an approved medicine built to copy one, or a compound that has only ever been tested in a dish. The word alone tells you nothing about the evidence.
One practical consequence: most peptides do not survive digestion well, which is why so many are injected rather than swallowed. Any oral version raises an extra question before all the others, which is whether enough of it gets where it is going at all.
Why everyone is suddenly talking about them
Two things happened at once. GLP-1 medicines put the word “peptide” in millions of ordinary conversations, and they are genuinely peptides with genuinely strong evidence. At the same time, a large market of compounds sold “for research use only” grew up online, borrowing that credibility for molecules with a fraction of the data.
The result is a feed where an approved medicine studied in tens of thousands of people and a compound studied in forty mice are discussed in the same tone, with the same confidence, often in the same video. That gap is the whole reason this site exists.
How to read a study
You do not need a science degree. You need six questions, asked in order, every time.
Cells, animals, or people?
A result in a dish or a mouse is a reason to study something in humans. It is not a human result.
How many people?
Twelve volunteers and twelve hundred patients are both “a human study.” Sample size is the first thing to look for and the last thing a headline mentions.
Was there a comparison group?
Without a placebo or control arm, improvement could be time, expectation, or everything else that changed that month.
What was measured, and for how long?
A blood marker at four weeks is not a symptom at one year. Check that the outcome measured is the outcome you care about.
Who paid for it, and was it peer-reviewed?
Funding does not make a study wrong. It does make you read it more carefully. A preprint has not been peer-reviewed yet.
Has anyone repeated it?
One study is a signal. A second, independent study that finds the same thing is when a signal starts to become knowledge.
The evidence ladder
Every sheet in the index carries a rail with six dots. The dots are the ladder below, from a mechanism on paper to settled medicine. A filled dot means research exists at that rung. A half dot means it exists but the data is small, early, or thin. An empty dot means nobody has done that work yet.
Mechanistic
A plausible biological story about how it could work. No study has tested it yet.
Cell research
Tested on cells in a dish. Useful for mechanism, silent on what happens in a body.
Animal research
Studied in mice, rats, or other animals. Most peptide headlines live here.
Human observational
People were observed, surveyed, or followed, or given the peptide in a small study with no comparison group. Useful for patterns, silent on cause.
Human clinical trial
A designed trial in people with a comparison group. The bar for a real claim.
Established clinical use
Approved, prescribed, and studied for years. Settled medicine.
The rail is an editorial judgment, not a score. We read the literature and place the dot where the evidence honestly sits. When new work comes out, the dot moves, and the sheet’s review date moves with it.
What the status stamp means
Status and evidence are separate questions, so every sheet shows them separately. Status is about the drug pathway. Evidence is about the science. A compound can have promising human data and no approval, or an approval for one condition and no data for the one people are asking about.
- FDA-approved
- Approved by the FDA for a specific use.
- FDA-approved for another indication
- Approved, but for a different condition than the one being discussed.
- Investigational
- Being studied in registered human trials. Not approved.
- Experimental
- Early research only. No approval pathway underway.
- Not FDA-approved
- Not approved for use as a drug. Often sold as a research chemical.
You will also see compounding news. In the United States, compounding pharmacies may use certain bulk substances under rules set by the FDA. An advisory committee can vote to recommend that a substance be added to that list, and the agency then makes a final decision. A committee vote is a recommendation, not an approval, and we say so every time it comes up.
What we will not do
- We will not tell you what to take, how much, or how often. That conversation belongs with a qualified clinician who knows your history.
- We will not name vendors or link to sellers. Our quality framework exists so you can evaluate any source yourself.
- We will not round an animal result up to a human claim, or a case report up to a trial.
- We will not pretend to certainty we do not have. Where the honest answer is “we do not know yet,” that is the answer.